Vktx nasdaq.

That number of contracts represents approximately 709,400 underlying shares, working out to a sizeable 51.3% of VKTX's average daily trading volume over the past month, of 1.4 million shares.About Institutional Holdings. Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and ... VKTX Viking Therapeutics Options Ahead of Earnings Analyzing the options chain and the chart patterns of VKTX Viking Therapeutics prior to the earnings report this week, I would consider purchasing the 11usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $1.80.Rasi Bhadramani. Viking Therapeutics (NASDAQ:VKTX) has been my top NASH stock for the past few years due to VK2809's performance, the company's cash position, and the reasonable valuation ...

12.28 USD. +6.23%. +8.96%. +30.64%. Nov. 14. Viking Therapeutics' Phase 2b of VK2809 to Treat Non-Alcoholic Steatohepatitis Meets Primary Endpoint; Shares Rise Early. MT. …

seekingalpha.com - August 22 at 1:56 AM. Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Bought by Barclays PLC. marketbeat.com - August 15 at 5:09 AM. Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes. msn.com - August 9 at 6:40 PM.

Find the latest Insider Activity data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com. Viking Therapeutics (VKTX 4.42%), a small-cap biotech, has been on quite the ride over the past few months.Thanks to a positive late-stage trial in nonalcoholic steatohepatitis (NASH) from rival ...VKTX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. VIKING THERAPEUTICS, INC. (VKTX) Compare. VIKING THERAPEUTICS, INC. 12.28 ...Based on analysts offering 12 month price targets for VKTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Mar 29, 2023 · Shares of Viking Therapeutics VKTX have surged almost 70% on Mar 28, after it announced positive clinical data of VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose ...

Fintel reports that on August 8, 2023, Stifel reiterated coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation.. Analyst Price Forecast Suggests 142.45% Upside. As of August 2 ...

Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.

Morphic Holding Inc. 23.40. +0.29. +1.25%. Get Viking Therapeutics Inc (VKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.18 oct 2023 ... Viking Therapeutics (NASDAQ:VKTX) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a ...צפה בגרף ‎Viking Therapeutics, Inc.‎ בזמן אמת כדי לעקוב אחר תנועת מחיר המניה. תמצא תחזיות שוק, ‎VKTX‎ וחדשות שוק כלכליות.VKTX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. VIKING THERAPEUTICS, INC. (VKTX) Compare. VIKING THERAPEUTICS, INC. 15.39 ...

VKTX VKTX AFTER HOURS QUOTE VKTX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ... ... Stock Market Index Fund Investor Shares, and IWM - iShares Russell 2000 ETF . Viking Therapeutics Inc (NASDAQ:VKTX) institutional ownership structure shows ...View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...VFS. VinFast Auto Ltd. Ordinary Shares. $17.15 -0.84 -4.67%. Find the latest news headlines from Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.View Premium Services. Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis.MSFT. Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Viking Therapeutics, Inc. Common Stock (VKTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ...NASDAQ:VKTX Viking Therapeutics (VKTX) Stock Forecast & Price Target $11.56 +0.21 (+1.85%) (As of 11/22/2023 ET) Compare Today's Range $11.21 $11.68 50 …

NASDAQ VKTX. Open. $12.01. Change. $0.69 (5.83%) Day's Range. $12.01 - $12.67. 52-Week Range. $3.54 - $25.72. Volume. 562.4K. Market Cap. $1.3B. Currency in USD. …Viking Therapeutics (NASDAQ: VKTX) has had a very promising 2023.They announced very good early results for an obesity drug in March. They then quickly used those good results to sell $250 million ...

A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VKTX shares currently have a short interest ratio of 9.0. Learn More on Viking Therapeutics's short interest ratio.VKTX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. VIKING THERAPEUTICS, INC. (VKTX) Compare. VIKING THERAPEUTICS, INC. 15.39 ...As of February 3, 2023, the average one-year price target for Viking Therapeutics is $18.70. The forecasts range from a low of $11.11 to a high of $31.50. The average price target represents an ...Viking Therapeutics Inc (NASDAQ:VKTX) $11.83 0.11[0.94%] Last update: 4:20PM (Delayed 15-Minutes) Get Real Time Here $11.83 0[0.00%] After-Hours News …The Viking Therapeutics stock price gained 0.94% on the last trading day (Wednesday, 29th Nov 2023), rising from $11.72 to $11.83. During the last trading day the stock fluctuated 4.26% from a day low at $11.74 to a day high of $12.24. The price has been going up and down for this period, and there has been a 5.91% gain for the last 2 weeks.Dec 1, 2023 · Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock. SAN DIEGO , March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic a... 8 months ago - PRNewsWire.

Find the latest dividend history for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.

Jun 29, 2023 · Turning to the calls side of the option chain, the call contract at the $18.00 strike price has a current bid of $1.05. If an investor was to purchase shares of VKTX stock at the current price ...

Back to VKTX Overview. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ...Viking Therapeutics, Inc. (VKTX-NASDAQ) 7 b t z This model is highly dependent upon continued clinical k c Current Price (01/23/19) $8.11 Valuation $28.00 -OUTLOOK SUMMARY DATA Risk Level52 High Type of Stock Small-Value Industry Med-Biomed/Gene 5 P/E using 2018 Estimate P/E using 2019 Estimate We’ve recently heard from investors …Viking Therapeutics Inc ( NASDAQ:VKTX) reported a strong quarter-end cash position of $376M. The company's net loss for Q3 2023 was $22.5 million, or $0.23 per share, compared to a net loss of $15 ...Nasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ...5 Best Weight Loss Stocks To Invest In Viking Therapeutics, Inc. (NASDAQ:VKTX) Q2 2023 Earnings Call Transcript 10 Stocks Wall Street Analysts and Billionaires Are Crazy About 15 Best-Performing ...Viking Therapeutics, Inc. (NASDAQ:VKTX) is developing treatments for liver diseases, post surgical complications, and other ailments. Despite a hefty short interest percentage, the firm's shares ...Oppenheimer analyst Jay Olson maintained a Buy rating on Viking Therapeutics ( VKTX – Research Report) yesterday and set a price target of $40.00. The company’s shares closed yesterday at $24. ...VKTX has move up from $4.00 a share to nearly $11.00 a share, largely in sympathy since those Madrigal trial results were announced. Therefore, I have taken profits on most of my small stake in VKTX.Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Earnings Call Transcript (Insider Monkey) Feb-08-23 04:05PM Viking Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update (PR Newswire) Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the …Viking Therapeutics (NASDAQ: VKTX) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial. This data comes from its Phase 1 study of ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Viking Therapeutics Inc (Symbol: VKTX), where a total of 11,518 contracts have traded ...Viking Therapeutics Inc (Symbol: VKTX) saw options trading volume of 5,067 contracts, representing approximately 506,700 underlying shares or approximately 53.5% of VKTX's average daily trading ...Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play.Instagram:https://instagram. automated trading strategiesreviews on plus500funded account stock tradinghnoi XBI, IMGN, VKTX, TGTX: ETF Outflow Alert. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF ... ben and jerry's boycottanonymous delaware llc If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can... best tech stocks to buy right now Price Volume Sep '23 Oct '23 Nov '23 Dec '23 $10 $8 $12 $14 $16 $18 0M 10M 20M 2020. Display Events. Dividends. Splits. Earnings. News. Chart Style. Line. Mountain. Dec 1, 2023 · Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock. SAN DIEGO , March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic a... 8 months ago - PRNewsWire.